ClinicalMetric / Countries / Netherlands / osteoarthritis hip
← 🇳🇱 Netherlands Trials
🇳🇱 Netherlands Country × Condition

osteoarthritis hip Clinical Trials in Netherlands

Active clinical trials for osteoarthritis hip with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands

Active Trials in Netherlands (3)

NCT04031820
Recruiting

Dual-mobility Cups Compared to Unipolar Cups on Dislocation and Cost-effectiveness After Primary Total Hip Arthroplasty.

Enrollment
1,100 pts
Country
🇳🇱 Netherlands
JointResearch
View Trial →
NCT06578182 Phase 3
Recruiting

The Effect of ColcHicine on the Incidence of Knee or Hip Replacements

Enrollment
1,410 pts
Country
🇳🇱 Netherlands
Sint Maartenskliniek
View Trial →
NCT06342843
Recruiting

Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH)

Enrollment
211 pts
Country
🇳🇱 Netherlands
Isala
View Trial →

Frequently Asked Questions

How many osteoarthritis hip clinical trials are active in Netherlands?
There are currently 3 active clinical trials for osteoarthritis hip with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a osteoarthritis hip clinical trial in Netherlands?
To join a osteoarthritis hip clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are osteoarthritis hip trials in Netherlands?
Active osteoarthritis hip trials in Netherlands span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Netherlands Trials → Global osteoarthritis hip Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology